INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 443m ago
HOUSE PTR42m ago
SEC 13F42m ago
ROBINHOOD CHAIN42m ago
Public company

CAPRICOR THERAPEUTICS, INC.

CAPRCIK 0001133869

EDGAR filingsOpen in network
Price$9.00
1 year+44.7%
Disclosed transactions13
Buys / sells0 / 2
Max Insider Score26
Connections with evidence7

CAPR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MT
Maurer Michael TCHIEF COMMERCIAL OFFICER
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
80.0K sh
May 26, 2026May 28, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    CHECKMATE GOVERNMENT RELATIONSLDA RR 2026 third quarter · Health issues · Sep 3, 2026
  • ← Insider ofevidence
    Maurer Michael TCHIEF COMMERCIAL OFFICER · May 28, 2026
  • ← Insider ofevidence
    Kelliher MikeDirector · Jan 7, 2026
  • ← Insider ofevidence
traded May 26, 2026
+2d
SEC FORM 4

Evidence

1
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$261K
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

22
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.67M
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

26
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$1.85M
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
53.7K sh
Apr 1, 2026Apr 1, 2026
traded Apr 1, 2026
+0dSEC FORM 4

Evidence

5
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M$298K
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

0
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
61.3K sh
Mar 31, 2026Apr 1, 2026
traded Mar 31, 2026
+1dSEC FORM 4

Evidence

9
SE
Sabar Karimah EsDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
1,360 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
5,420 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
GJ
Gotwals Philip JDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

9
KM
Kelliher MikeDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence

Sabar Karimah Es
Director · Jan 7, 2026
  • ← Insider ofevidence
    Auwaerter Paul GisbertDirector · Jan 7, 2026
  • ← Insider ofevidence
    Gotwals Philip JDirector · Jan 7, 2026

    • Lobbying

    $0 reported · de-duplicated
    2026 Q3 $0 via firms
    • CHECKMATE GOVERNMENT RELATIONS—2026 Q3 · posted Sep 3, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.